Core Viewpoint - The article highlights a significant breakthrough in China's universal healthcare system in 2025, with an increase in insured individuals and a notable shift in the financial balance of the healthcare fund, indicating a more stable and sustainable structure for medical insurance [3]. Group 1: Insurance Coverage - The number of individuals covered by basic medical insurance increased by 4.06 million in 2025, marking the first reversal since the peak population in 2021 [6]. - The structure of insurance coverage has improved, with employee insurance rising to 38.86 million, an increase of 9.08 million, while resident insurance decreased by 502,000, maintaining a coverage rate of 95% [6][7]. - The decline in resident insurance is attributed to natural population decrease and a shift of graduates to employee insurance, reflecting improved employment quality and economic conditions [6][9]. Group 2: Financial Performance of Healthcare Fund - In 2025, the total income of the basic medical insurance fund reached 35,873.11 billion yuan, a year-on-year increase of 2.7%, while total expenditure was 30,009.38 billion yuan, up 0.8% [11]. - This marks a critical turning point where income growth outpaced expenditure growth for the first time in years, enhancing the fund's stability and sustainability [11]. - The average daily expenditure exceeded 8 billion yuan, significantly impacting the healthcare industry and patient access to services [3][11]. Group 3: Changes in Healthcare Utilization - In 2025, outpatient services saw a significant increase, with 7.215 billion visits, a 25.51% year-on-year growth, while inpatient visits decreased to 278 million, a 3.40% decline [12]. - The average cost per inpatient visit was 8,509.28 yuan, while outpatient costs were significantly lower, indicating a shift towards more efficient healthcare delivery [12][13]. - The increase in outpatient services and decrease in inpatient admissions are attributed to reforms in the medical payment system and improved efficiency in the healthcare system [12][13]. Group 4: Support for Medical Innovation - The healthcare fund has become a crucial driver for medical innovation, with 949 new drugs added to the insurance directory since 2018, including 114 in 2025 [15]. - The total number of drugs in the insurance directory reached 3,253, with over 700 billion yuan in sales for newly negotiated drugs from 2018 to 2025 [15]. - The establishment of a unified pricing system for medical services has facilitated the introduction of new medical products and services, further supporting innovation in the healthcare sector [15].